The leader peptide of recombinant manganese superoxide dismutase (rMnSOD-Lp) should be used as a molecular vehicle to transportcisplatin directly into cancer cells since it delivers about four times more cisplatin to HTB-112 cells. Here, SOD2 is linked to cancer.